Sign in

W. R. Berkley Corporation WRB

Price 69.5 USD
as of 2026-09-04
56/100
No view
Quality64
Growth49
Balance-sheet strength56
Valuation66
Momentum45
Income38

Composite 56/100; the shares have moved about 22% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Income ranks 38/100 — a slight mark against it.

Case for

Valuation ranks 66/100 — a moderate point in its favour. Quality ranks 64/100 — a moderate point in its favour. Balance-sheet strength ranks 56/100 — a slight point in its favour.

Case against

Income ranks 38/100 — a slight mark against it. Momentum ranks 45/100 — a slight mark against it. Growth ranks 49/100 — a slight mark against it.

What the company does W. R. Berkley Corporation underwrites specialty commercial property and casualty insurance globally across admitted, excess & surplus, and reinsurance lines, including cyber, medical professional, workers compensation, and fine arts coverage.

Key financials ROE 20.2%, ROA 3.6%, gross margin 43.8%, operating margin 16.4%, net margin 12.9%. Revenue grew 7.8% while EPS grew 2.4%. Debt/equity is 0.32 with a current ratio of 0.41.

Stock health SideraVIA scores: Quality 63.4, Growth 51.5, Strength 56.0, Valuation 66.3, Momentum 42.0, Income 38.8. Piotroski F-Score is 6/9. RSI(14) is 35.50.

Price vs fair value The stock trades at a discount of 2.90% versus the analyst mean target of 69.53. - Underwriting discipline cited as margin-supportive amid soft pricing (2026-08-28) - Forward P/E 14.31 below trailing P/E 14.05, suggesting valuation support - Net margins 12.9% and ROE 20.2% indicate operational strength - Momentum score 42.0 and RSI 35.50 reflect weak near-term price momentum

Looking forward Forward earnings multiple of 14.31x and strong capital metrics suggest steady performance, but soft pricing and weak momentum may cap near-term appreciation.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.